Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-13
SponsorSeoul National University Bundang Hospital
About this trial
The purpose of this study is to evaluate the effectiveness of the AI-based application "HiDongDong" in improving articulation development in children aged 2 to under 14 years with suspected articulation delays. The program provides individualized language training based on a personalized assessment of vulnerable speech sounds. This trial aims to determine whether the digital therapeutic solution can enhance articulation skills and inform future strategies for language rehabilitation in children.
Eligibility criteria
Qualifiers
Children aged 2 years to under 14 years
Persistent difficulties in speech sound production, or reduced speech intelligibility that interferes with communicative participation, resulting in limitations in social participation, academic performance, or daily activities
Articulation developmental delay suspected based on U-TAP results, with articulation performance more than 1 standard deviation below the mean for the same age group (-1SD)
Sufficient cognitive ability to follow simple instructions via a mobile device (tablet)
Disqualifiers
Caregiver or child does not consent to study participation, or withdraws consent during the study
U-TAP results indicate articulation development within the normal range, with no suspicion of articulation developmental delay
Difficulty understanding simple instructions or participating in assessments and training due to moderate or severe cognitive impairment, attention deficit, autism spectrum disorder, or similar conditions
Significantly limited speech production due to neuromuscular or anatomical causes, including severe visual impairment or visual field deficits, hearing impairment, cleft palate structural abnormalities, or severe oral/facial muscle dysfunction, resulting in difficulty with articulation
Trial design
Treatments tested in this trial
- HiDongDong Intervention
- Standard Care / Speech Therapist Intervention
Treatment groups
48 Participants
are divided into 2 treatment groupsSponsors and collaborators
Seoul National University Bundang Hospital
Lead sponsor
National IT Industry Promotion Agency, Republic of Korea
Collaborator
Source ClinicalTrials.gov